Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Anticancer Research|April 27, 1999
TUM2-PK (pyruvate kinase type tumor M2), CA19-9 and CEA in patients with benign, malignant and metastasizing pancreatic lesionsH Cerwenka, R Aigner, H Bacher, et al.
Hepato-Gastroenterology|July 31, 1998
Antioxidant treatment during liver resection for alleviation of ischemia-reperfusion injuryH Cerwenka, H Bacher, G Werkgartner, et al.
Anticancer Research|June 9, 2001
Pancreatitis-associated protein (PAP) in patients with pancreatic cancerH Cerwenka, R Aigner, H Bacher, et al.
Diseases of the Colon and Rectum|July 1, 1997
Local nitroglycerin for treatment of anal fissures: an alternative to lateral sphincterotomy?H Bacher, H J Mischinger, G Werkgartner, et al.
Life Sciences|February 5, 2000
Liver ischemia, catecholamines and preoperative condition influencing postoperative tachycardia in liver surgeryH Bacher, H J Mischinger, H Cerwenka, et al.
Chemotherapy|October 18, 2005
Treatment of patients with pyogenic liver abscessH Cerwenka, H Bacher, G Werkgartner, et al.
International Journal of Colorectal Disease|December 17, 2014
Laparoscopic versus open appendectomy for complicated appendicitis in high risk patientsG Werkgartner, H Cerwenka, A El Shabrawi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 1, 1997
Cystic retroperitoneal lymphangiomas in adultsH Hauser, H J Mischinger, A Beham, et al.
Surgical Endoscopy|July 1, 1997
Percutaneous endoscopic gastrostomy (PEG). 8 years of clinical experience in 232 patientsW Amann, H J Mischinger, A Berger, et al.
Free Radical Research|July 10, 1999
Normothermic liver ischemia and antioxidant treatment during hepatic resectionsH Cerwenka, G Khoschsorur, H Bacher, et al.
Pageof 3